Healthcare

HB 269 amends Pennsylvania's Controlled Substance Act to improve access to overdose response information. It requires the Department of Health to develop free online training materials, posters, and pamphlets about recognizing opioid overdoses and using reversal medications (like naloxone), with the materials available in multiple languages upon request. Specific public entities - including Commonwealth agencies, transit authorities, municipalities, and local transportation organizations - must display the poster in conspicuous public locations, such as bathrooms or lobbies. The Department covers all printing and distribution costs, and entities already displaying equivalent materials may substitute them with prior notice. This bill focuses on education and resource accessibility, not changing drug laws or medication access.

HB 409 amends Pennsylvania's Patient Test Result Information Act to require healthcare providers to give patients written notice at the time of diagnostic imaging services (like X-rays, MRIs, and ultrasounds) about how to access their results, including online portals or mail (with a possible fee for mailing). It also mandates a follow-up notice within 20 days if a significant abnormality is found, including details like the test date and ordering doctor's name, unless exceptions apply. Exceptions include routine obstetrical ultrasounds, inpatient or emergency care, diagnostic radiographs (X-rays), and patients with chronic conditions who were previously notified. This bill directly affects patients receiving diagnostic imaging and the healthcare facilities performing these services.